Indirect Treatment Comparisons of Ibrutinib Versus Physician’s Choice and Idelalisib Plus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia
Autor: | Sorensen, Sonja, Wildgust, Mark, Sengupta, Nishan, Trambitas, Cristina, Diels, Joris, van Sanden, Suzy, Xu, Yingxin, Dorman, Emily |
---|---|
Zdroj: | In Clinical Therapeutics January 2017 39(1):178-189 |
Databáze: | ScienceDirect |
Externí odkaz: |